Hariprasad Vankayalapati
Company: Biolexis Therapeutics
Job title: Chief Scientific Officer
Seminars:
Design & Development of Novel GPCR Targeting Small Molecule Agonists with the Application of Quenched Molecular Dynamic (QMD) Simulations 2:00 pm
Generation of physiologicaly relevant conformers, binding mode, design of peptidomimetics by constraining peptide backbone, we develop orally available peptide or small molecules Further profiling against several GPCR family member target proteins for selectivity and stability for targeted treatment Generate natural peptide sequence to a stable conformer, search for amide back-bone, alpha-C, acid and amine mimetic…Read more
day: Conference Day One
Fireside Chat: Examining the Future Possibilities of Modalities for GPCRTargeted Drugs to Become More Effective & Feasible 4:00 pm
How can we begin to develop orally available peptides? How do you turn a peptide starting point into a small molecule drug? What are the other modalities that can be employed to target GPCRs? Do some modalities lend themselves better to specific indications/GPCRs?Read more
day: Conference Day One
Chair’s Opening Remarks 8:55 am
day: Conference Day One